BIOS HEALTH
Digital Catapult helped position BIOS as a ground-breaking scaleup raising $4.5 million
2019 Winners
2019
About BIOS Health
BIOS combines neural engineering with AI to leverage the nervous system to enable more effective treatments for a range of chronic conditions. BIOS is positioned to be the platform on which a new generation of AI treatments can be built to help billions of people suffering from chronic disease to improve their quality of life.
Impact
How Digital Catapult’s programme has led to commercial success for BIOS
$4.5 million in seed
Raised $4.5 million in seed funding from 5+ investors
International growth
Opened new R&D office in Montreal, Canada
Over £1 million in grants
Won research grants worth over £1 million in total from Innovate UK, SBRI, and NIHR to support clinical validation trials for its AI tools
A quote from the team
“We’ve been extremely fortunate to have worked closely with Digital Catapult for almost four years, helping us along the way from just starting out and into maturity and scaling. They have helped us make the right connections where we needed them, including helping us secure a £100,000 Innovate UK grant”
From the judges
One of the first five companies to join Digital Catapult’s Machine Intelligence Garage programme, BIOS has raised $4.5 million in seed funding and won research grants of over £1 million. The judges recognised this company’s ground-breaking combination of neural engineering and artificial intelligence to improve quality of life.
More about BIOS and their work
The BIOS platform interprets the hidden language of the brain to enable more effective treatments for a range of chronic conditions, from heart disease to diabetes. Its hardware interface and machine learning software enables clinical experts to discover, translate, and scale new algorithmic treatments that are personalised, responsive and targeted. BIOS is positioned to be the platform on which a new generation of AI treatments can be built so that it can help billions of people suffering from chronic disease to improve their quality of life.
The BIOS team combines applied materials, machine learning, software, and neuroscience with the experience of surgeons, clinicians and patients. In addition, BIOS has generated the largest peripheral neural data set in the world and is leading cutting-edge machine learning research in the neuromodulation and bioelectronic medicine fields.
Since BIOS was founded during MassChallenge UK in 2015, which Digital Catapult sponsored, it has been working very closely with Digital Catapult. The staff have been incredibly supportive in terms of access to experts and connections, and space for BIOS to use for everything from filming to meetings. BIOS has most recently been a founding member of the Machine Intelligence Garage, which has been a highly beneficial programme as well. Working with Digital Catapult has been an invaluable relationship for BIOS and it is truly grateful for its ongoing involvement and support.
